Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment
TAMPA, Fla. — The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for ...
TAMPA, Fla. — The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for ...
A team of University of Virginia researchers released the first-ever database of hurricane evacuation orders in the United States. By ...
WASHINGTON, D.C.—In support of President Biden’s Investing in America agenda, the U.S. Department of Energy (DOE) today announced awards totaling ...
New in-depth review highlights need for more humane antiracist genomics literacy and cross-disciplinary teaching methods to promote a more inclusive ...
Rice University’s Emilia Morosan has been selected as one of 11 scientists and engineers for the 2024 Vannevar Bush Faculty ...
FOR IMMEDIATE RELEASE: July 18, 2024 CONTACT: Camille Jewell, cjewell@vancomm.com or 202-248-5460 FOR IMMEDIATE RELEASE: July 18, 2024 CONTACT: Camille ...
In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based ...
A large-scale genome-wide association study (GWAS) using data from the United States Department of Veterans Affairs (VA) Million Veterans Program ...
Physical exercise is associated with fewer depression symptoms in people with osteoarthritis, even - and especially - in those who ...
COLUMBUS, Ohio – By harnessing the power of machine learning, researchers have constructed a framework for analyzing what factors most ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine